Literature DB >> 4335371

The spectrum of infections with Epstein-Barr virus: a hypothesis.

A S Evans.   

Abstract

Mesh：

Substances：

Year:  1971        PMID： 4335371     DOI： 10.1093/infdis/124.3.330

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  23 in total

1.  Human tumor viruses.

Authors:  W S Robinson
Journal:  Calif Med       Date:  1973-10

2.  [Chronic pseudomalignant immuneproliferation (Canale-Smith syndrome) (author's transl)].

Authors:  K Kellerer; I Mutz
Journal:  Eur J Pediatr       Date:  1976-02-04       Impact factor: 3.183

Review 3.  Epstein-barr virus: environmental trigger of multiple sclerosis?

Authors:  Jan D Lünemann; Thomas Kamradt; Roland Martin; Christian Münz
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

4.  Infectious mononucleosis and mononucleosis syndromes.

Authors:  M Fiala; D C Heiner; J A Turner; B Rosenbloom; L B Guze
Journal:  West J Med       Date:  1977-06

Review 5.  Infectious diseases: annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1972-06       Impact factor: 2.401

6.  Epstein-Barr virus infections.

Authors:  P J Middleton
Journal:  Can Med Assoc J       Date:  1974-01-05       Impact factor: 8.262

7.  Clinical and laboratory aspects of raised virus antibody titres in systemic lupus erythematosus.

Authors:  N F Rothfield; A S Evans; J C Niederman
Journal:  Ann Rheum Dis       Date:  1973-05       Impact factor: 19.103

8.  Malignant lymphomas of African children.

Authors:  A Stewart; J N Davies; G Dalldorf; F E Barnhart
Journal:  Proc Natl Acad Sci U S A       Date:  1973-01       Impact factor: 11.205

Review 9.  Epstein-Barr virus and multiple sclerosis.

Authors:  Jan D Lünemann; Christian Münz
Journal:  Curr Neurol Neurosci Rep       Date:  2007-05       Impact factor: 5.081

10.  Increased risk of malignant lymphoma indicated by elevated Epstein-Barr virus antibodies--a prospective study.

Authors:  T Lehtinen; J Lumio; J Dillner; M Hakama; P Knekt; M Lehtinen; L Teppo; P Leinikki
Journal:  Cancer Causes Control       Date:  1993-05       Impact factor: 2.506
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.